Artiva Biotherapeutics (ARTV) Capital Expenditures (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Capital Expenditures came in at $242000.0 in Q1 2026, down 72.56% year-on-year from $882000.0 in Q1 2025, and up 202.98% on a QoQ basis from -$235000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Capital Expenditures (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Capital Expenditures data on file, last reported at $242000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 72.56% year-over-year to $242000.0 in Q1 2026; TTM through Mar 2026 was -$449000.0, a 148.49% decrease from a year earlier, with the FY2025 full-year figure at $191000.0, up 235.09% from the prior year.
- Capital Expenditures for Q1 2026 stood at $242000.0, up from -$235000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for ARTV reached as high as $2.7 million in Q3 2023 and fell as low as -$2.8 million in Q4 2023.
- Historically, Capital Expenditures has averaged $37636.4 across 4 years, with a median of $143000.0 in 2025.
- On a YoY basis, Capital Expenditures climbed as much as 6684.62% in 2025 and fell as far as 255.63% in 2025.
- Year by year, Capital Expenditures stood at -$2.8 million in 2023, then jumped by 105.47% to $151000.0 in 2024, then sank by 255.63% to -$235000.0 in 2025, then jumped by 202.98% to $242000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $242000.0 in Q1 2026, -$235000.0 in Q4 2025, and $143000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | 242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | -235,000.00 |
| Dec 31, 2025 | -235,000.00 |
| Sep 30, 2025 | 143,000.00 |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | -576,000.00 |
| Sep 30, 2024 | -576,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | -2.76 Mn |
| Dec 31, 2023 | -2.76 Mn |